Trial NCT01744912

View at ClinicalTrials.gov 
Org. Study IDs: TGTX 1101-102

Last trial update was posted on 2022-05-11

MeSH Interventions

Lenalidomide

MeSH Conditions

Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma Lymphoma, Mantle-Cell Waldenstrom Macroglobulinemia

Other Conditions

B-cell Lymphomas Chronic Lymphocytic Leukemia Mantle Cell Lymphoma Marginal Zone Lymphoma Non-Hodgkins Lymphoma Small Lymphocytic Lymphoma Waldenstrom's Macroglobulinemia

Stopping Reasons

Sponsor's decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID